Status:
COMPLETED
Afamin in Gestational Diabetes Mellitus
Lead Sponsor:
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Collaborating Sponsors:
Ankara University
Conditions:
Gestational Diabetes Mellitus in Pregnancy
Eligibility:
FEMALE
18-35 years
Brief Summary
This study includes pregnancies in 11 to 14 th gestational weeks. Investigators will sample maternal plasma in the first trimester and analyze maternal plasma afamin values. All these women will then ...
Detailed Description
Background Gestational diabetes mellitus (GDM) is an endocrinopathy that occurs during pregnancy, and presents several clinical findings together with increased blood glucose levels. The frequency of ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- singleton pregnancy,
- having no fetal anomalies
- having no pregestational diabetes
- having no underlying chronic diseases (hypertension, thyroid dysfunction, other endocrinopathies, autoimmune disorders)
- age \>18 or \< 35 years
- fasting glucose level \< 105 mg/dL
- Exclusion Criteria:
- multiple pregnancy
- fetal anomalies
- pregestational diabetes
- underlying chronic diseases (hypertension, thyroid dysfunction, other endocrinopathies, autoimmune disorders)
- age \<18 or \> 35 years
- fasting glucose level \> 105 mg/dL or random glucose level \> 200 mg/dL
Exclusion
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04054843
Start Date
September 1 2019
End Date
March 15 2020
Last Update
December 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Etlik Zubeyde Hanım Women's Health Care, Training and Research Hospital
Ankara, Turkey (Türkiye)